✦ LIBER ✦

The impact of kidney function on the outcome of metastatic renal cell carcinoma patients treated with vascular endothelial growth factor-targeted therapy

✍ Scribed by Robyn Macfarlane; Daniel Y. C. Heng; Wanling Xie; Jennifer J. Knox; David F. McDermott; Brian I. Rini; Christian Kollmannsberger; Toni K. Choueiri

Publisher: John Wiley and Sons
Year: 2011
Tongue: English
Weight: 130 KB
Volume: 118
Category: Article
ISSN: 0008-543X
DOI: 10.1002/cncr.26201

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clinical factors associated with outcome

Clinical factors associated with outcome in patients with metastatic clear-cell renal cell carcinoma treated with vascular endothelial growth factor-targeted therapy

✍ Toni K. Choueiri; Jorge A. Garcia; Paul Elson; Mohamad Khasawneh; Saif Usman; Al 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 124 KB 👁 2 views

## Abstract ## BACKGROUND. Therapy targeted against the vascular endothelial growth factor (VEGF) pathway is a standard of care for patients with metastatic renal cell carcinoma (RCC). The identification of patients who are more likely to benefit from these agents is warranted. ## METHODS. In to

Vascular endothelial growth factor-targe

Vascular endothelial growth factor-targeted therapy for the treatment of adult metastatic Xp11.2 translocation renal cell carcinoma

✍ Toni K. Choueiri; Zita Dubauskas Lim; Michelle S. Hirsch; Pheroze Tamboli; Eric 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 315 KB 👁 1 views

Patterns of disease progression in metas

Patterns of disease progression in metastatic renal cell carcinoma patients treated with antivascular agents and interferon : Impact of therapy on recurrence patterns and outcome measures

✍ Elizabeth R. Plimack; Nizar Tannir; E Lin; B. Nebiyou Bekele; Eric Jonasch 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 234 KB 👁 1 views